Molecular Switch Driving Triple-Negative Breast Cancer Metastasis Identified

Molecular Switch Driving Triple-Negative Breast Cancer Metastasis Identified

A new study identifies a novel signaling state that may predict metastatic risk and CDK4/6 inhibitor sensitivity in TNBC.

Scientists identify molecule driving one of the deadliest forms of breast cancer

Australian researchers have uncovered a promising new way to tackle one of the most aggressive forms of breast cancer, raising hopes for more effective treatments to stop the disease from spreading.

Scientists discover molecule fueling one of breast cancer’s deadliest

Australian researchers have identified a molecular vulnerability that could help explain why triple-negative breast cancer so readily spreads through the body—and may have revealed a way to repurpose an existing cancer drug against it. The study, led by scientists at Adelaide University and the Olivia Newton-John Cancer Research Institute, describes a regulatory system involving a small RNA molecule called miR-342 and a cancer-associated pathway…